Metagenomi Therapeutics, Inc. (MGX) ROE
- 2026-06-30: ROE -83.03%.
- 2026-03-31: ROE -62.33%.
- 2025-12-31: ROE -55.40%.
- 2025-09-30: ROE -49.73%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -83.03% |
| 2026-03-31 | -62.33% |
| 2025-12-31 | -55.40% |
| 2025-09-30 | -49.73% |
| 2025-06-30 | -44.49% |
| 2025-03-31 | -36.65% |
| 2024-12-31 | -33.24% |
| 2024-09-30 | -28.91% |
| 2024-06-30 | -27.84% |
| 2024-03-31 | -28.03% |
| 2023-12-31 | 50.34% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -55.40% |
| 2024-12-31 | -33.24% |
| 2023-12-31 | 50.34% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |